Private Capital Group, LLC Novo Nordisk A S Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Private Capital Group, LLC holds 2,393 shares of NVO stock, worth $209,435. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,393

Previous 3,052 21.59%

Holding current value

$209,435

Previous $342,000 21.93%

% of portfolio

0.2%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$103.24 - $121.81 $68,035 - $80,272	-659 Reduced 21.59%	2,393 $267,000
Q1 2022 Apr 21, 2022	SELL	$93.1 - $112.54 $5,772 - $6,977	-62 Reduced 1.99%	3,052 $342,000
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $8,629 - $10,537	-90 Reduced 2.81%	3,114 $349,000
Q3 2021 Oct 13, 2021	BUY	$84.42 - $106.62 $54,366 - $68,663	644 Added 25.16%	3,204 $308,000
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $10,487 - $13,137	155 Added 6.44%	2,560 $215,000
Q1 2021 Apr 12, 2021	SELL	$67.06 - $75.82 $497,920 - $562,963	-7,425 Reduced 75.53%	2,405 $164,000
Q4 2020 Jan 26, 2021	BUY	$63.89 - $73.8 $7,666 - $8,856	120 Added 1.24%	9,830 $687,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $28,533 - $31,458	-448 Reduced 4.41%	9,710 $674,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $92,844 - $107,752	-1,586 Reduced 13.5%	10,158 $665,000
Q1 2020 May 07, 2020	BUY	$49.46 - $64.78 $186,365 - $244,091	3,768 Added 47.24%	11,744 $716,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $3,739 - $4,369	-75 Reduced 0.93%	7,976 $461,000
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $194,105 - $218,154	4,083 Added 102.9%	8,051 $416,000
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $202,366 - $226,932	-4,325 Reduced 52.15%	3,968 $183,000
Q1 2019 Apr 26, 2019	BUY	$46.36 - $52.63 $116,409 - $132,153	2,511 Added 43.43%	8,293 $438,000
Q4 2018 Jan 28, 2019	BUY	$41.54 - $47.25 $80,130 - $91,145	1,929 Added 50.06%	5,782 $266,000
Q3 2018 Oct 31, 2018	SELL	$46.76 - $51.24 $12,999 - $14,244	-278 Reduced 6.73%	3,853 $181,000
Q2 2018 Aug 09, 2018	BUY	$44.29 - $50.42 $5,580 - $6,352	126 Added 3.15%	4,131 $190,000
Q1 2018 May 16, 2018	SELL	$48.49 - $58.14 $872 - $1,046	-18 Reduced 0.45%	4,005 $200,000
Q4 2017 May 18, 2018	BUY	$47.53 - $53.73 $183,465 - $207,397	3,860 Added 2368.1%	4,023 $216,000
Q4 2017 Mar 07, 2018	BUY	$47.53 - $53.73 $7,747 - $8,757	163	163 $12,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Novo Nordisk A S Transaction History